Shinji Kobuchi

654 total citations
61 papers, 529 citations indexed

About

Shinji Kobuchi is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Shinji Kobuchi has authored 61 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 13 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in Shinji Kobuchi's work include Colorectal Cancer Treatments and Studies (23 papers), Cancer Treatment and Pharmacology (18 papers) and Pancreatic and Hepatic Oncology Research (9 papers). Shinji Kobuchi is often cited by papers focused on Colorectal Cancer Treatments and Studies (23 papers), Cancer Treatment and Pharmacology (18 papers) and Pancreatic and Hepatic Oncology Research (9 papers). Shinji Kobuchi collaborates with scholars based in Japan, Taiwan and United States. Shinji Kobuchi's co-authors include Yukako Ιtο, Toshiyuki Sakaeda, Kanji Takada, Keizo Fukushima, Nobuyuki Sugioka, Hiroaki Aoyama, Masakazu SHIBATA, Nobuhito Shibata, Taro Hayakawa and Asako Nishimura and has published in prestigious journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Shinji Kobuchi

58 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shinji Kobuchi Japan 13 198 122 104 61 60 61 529
Archie Thurston United States 12 124 0.6× 166 1.4× 62 0.6× 18 0.3× 72 1.2× 18 496
Christian Zimmermann Germany 14 322 1.6× 118 1.0× 27 0.3× 43 0.7× 93 1.6× 21 622
Blisse Vakkalagadda United States 10 79 0.4× 103 0.8× 67 0.6× 15 0.2× 52 0.9× 14 379
Hossein M. Elbadawy Saudi Arabia 13 45 0.2× 148 1.2× 58 0.6× 36 0.6× 28 0.5× 50 570
Amitabh Prakash New Zealand 11 48 0.2× 61 0.5× 64 0.6× 69 1.1× 44 0.7× 16 623
T.J. Nevalainen Finland 10 75 0.4× 124 1.0× 54 0.5× 38 0.6× 21 0.3× 16 568
Henri Humbert France 15 55 0.3× 77 0.6× 43 0.4× 56 0.9× 71 1.2× 33 590
Johannes B. van Bree Netherlands 11 203 1.0× 141 1.2× 316 3.0× 202 3.3× 77 1.3× 13 1.2k
Yoon‐Jee Chae South Korea 11 74 0.4× 90 0.7× 23 0.2× 32 0.5× 28 0.5× 48 311
Örjan Ahrenstedt Sweden 8 219 1.1× 80 0.7× 184 1.8× 57 0.9× 52 0.9× 12 636

Countries citing papers authored by Shinji Kobuchi

Since Specialization
Citations

This map shows the geographic impact of Shinji Kobuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinji Kobuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinji Kobuchi more than expected).

Fields of papers citing papers by Shinji Kobuchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinji Kobuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinji Kobuchi. The network helps show where Shinji Kobuchi may publish in the future.

Co-authorship network of co-authors of Shinji Kobuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Shinji Kobuchi. A scholar is included among the top collaborators of Shinji Kobuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinji Kobuchi. Shinji Kobuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kobuchi, Shinji, M. ARIMOTO, & Yukako Ιtο. (2024). Translational Pharmacokinetic-Toxicodynamic Model of Myelosuppression for Dose Optimization in Combination Chemotherapy of Capecitabine and Oxaliplatin from Rats to Humans. Journal of Pharmacology and Experimental Therapeutics. 390(3). 318–330. 2 indexed citations
2.
Kobuchi, Shinji, et al.. (2023). A Pharmacokinetic-Pharmacodynamic Model Predicts Uracil-tegafur Effect on Tumor Shrinkage and Myelosuppression in a Colorectal Cancer Rat Model. Anticancer Research. 43(3). 1121–1130. 3 indexed citations
3.
4.
Ιtο, Yukako, Shinji Kobuchi, Kikuko Amagase, et al.. (2023). Mobilization of Circulating Tumor Cells after Short- and Long-Term FOLFIRINOX and GEM/nab-PTX Chemotherapy in Xenograft Mouse Models of Human Pancreatic Cancer. Cancers. 15(22). 5482–5482. 3 indexed citations
5.
6.
7.
Kobuchi, Shinji & Yukako Ιtο. (2020). Application of Pharmacometrics of 5-Fluorouracil to Personalized Medicine: A Tool for Predicting Pharmacokinetic–Pharmacodynamic/Toxicodynamic Responses. Anticancer Research. 40(12). 6585–6597. 14 indexed citations
8.
Kobuchi, Shinji, et al.. (2020). Assessment of pharmacokinetic variations of capecitabine after multiple administration in rats: a physiologically based pharmacokinetic model. Cancer Chemotherapy and Pharmacology. 85(5). 869–880. 8 indexed citations
9.
Kobuchi, Shinji, et al.. (2019). Pharmacokinetics and lung distribution of macrolide antibiotics in sepsis model rats. Xenobiotica. 50(5). 552–558. 9 indexed citations
10.
Nakao, Keiko, Shinji Kobuchi, Akihiro Tamiya, et al.. (2019). Population pharmacokinetics of afatinib and exposure-safety relationships in Japanese patients with EGFR mutation-positive non-small cell lung cancer. Scientific Reports. 9(1). 18202–18202. 24 indexed citations
11.
Kobuchi, Shinji, et al.. (2016). A Simple and Rapid LC–MS/MS Method for Quantitation of Luseogliflozin in Rat Plasma and its Application to A PK Study. Bioanalysis. 9(2). 163–171. 3 indexed citations
12.
Kobuchi, Shinji, Yukako Ιtο, & Toshiyuki Sakaeda. (2016). Population Pharmacokinetic–Pharmacodynamic Modeling of 5-Fluorouracil for Toxicities in Rats. European Journal of Drug Metabolism and Pharmacokinetics. 42(4). 707–718. 10 indexed citations
13.
Kobuchi, Shinji, Chiaki Inoue, Hiroyuki Murakami, et al.. (2016). Transport of Azithromycin into Extravascular Space in Rats. Antimicrobial Agents and Chemotherapy. 60(11). 6823–6827. 8 indexed citations
14.
Kobuchi, Shinji, et al.. (2016). Effects of a bolus injection of 5-fluorouracil on dihydropyrimidine dehydrogenase activity in rats receiving continuous infusion of 5-fluorouracil. Cancer Chemotherapy and Pharmacology. 78(3). 517–523. 2 indexed citations
15.
16.
Kobuchi, Shinji, Yukako Ιtο, Taro Hayakawa, et al.. (2014). Pharmacokinetic–pharmacodynamic (PK–PD) modeling and simulation of 5-fluorouracil for erythropenia in rats. Journal of Pharmacological and Toxicological Methods. 70(2). 134–144. 11 indexed citations
17.
Kobuchi, Shinji, et al.. (2013). Effects of oxidative stress on the pharmacokinetics and hepatic metabolism of atazanavir in rats. Free Radical Research. 47(4). 291–300. 7 indexed citations
18.
Kobuchi, Shinji, Keizo Fukushima, Hiroaki Aoyama, et al.. (2013). Effects of Obesity Induced by High-Fat Diet on the Pharmacokinetics of Atazanavir in Rats. Drug Metabolism Letters. 7(1). 39–46. 4 indexed citations
19.
Fukushima, Keizo, et al.. (2013). Time-Dependent Interaction of Ritonavir in Chronic Use: The Power Balance Between Inhibition and Induction of P-Glycoprotein and Cytochrome P450 3A. Journal of Pharmaceutical Sciences. 102(6). 2044–2055. 13 indexed citations
20.
Fukushima, Keizo, Shinji Kobuchi, Masakazu SHIBATA, Kanji Takada, & Nobuyuki Sugioka. (2011). Decrease in Brain Distribution of Fluvoxamine in Experimental Hyperlipidemic Rats. Journal of Pharmacy & Pharmaceutical Sciences. 14(3). 414–414. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Archie Thurston Breakdown of academic impact, for papers by Christian Zimmermann Breakdown of academic impact, for papers by Blisse Vakkalagadda Breakdown of academic impact, for papers by Hossein M. Elbadawy Breakdown of academic impact, for papers by Amitabh Prakash Breakdown of academic impact, for papers by T.J. Nevalainen Breakdown of academic impact, for papers by Henri Humbert Breakdown of academic impact, for papers by Johannes B. van Bree Breakdown of academic impact, for papers by Yoon‐Jee Chae Breakdown of academic impact, for papers by Örjan Ahrenstedt
Rankless by CCL
2026